2022 |
The association between conception history and subsequent postpartum depression and/or anxiety: Evidence from the Clinical Practice Research Datalink 1991-2013
10.1016/j.jad.2022.04.138
Authors: F. Tianyi, Y. Li, F. Alderdice, M. Quigley, J. Kurinczuk, C. Bankhead, C. Carson |
2022 |
Prevalence and Patient Outcomes of Adult Primary Hypercholesterolemia and Dyslipidemia in the UK: Longitudinal Retrospective Study Using a Primary Care Dataset from 2009 to 2019
10.2147/ceor.s347085
Authors: A. Bilitou, J. Were, A. Farrer, A. Rabe, S. W. Y. Ming, I. Haq, K. Dunton |
2022 |
The sexual and reproductive health of women with mental illness: a primary care registry study
10.1007/s00737-022-01214-y
Authors: H. Hope, M. Pierce, E. Johnstone, J. Myers, K. Abel |
2022 |
Mapping the risk of infections in patients with multiple sclerosis: A multi-database study in the United Kingdom Clinical Practice Research Datalink GOLD and Aurum
10.1177/13524585221094218
Authors: M. Leung, M. Bazelier, P. Souverein, B. Uitdehaag, O. Klungel, H. Leufkens, R. Pajouheshnia |
2022 |
Intensity of care in cancer patients in the last year of life: a retrospective data linkage study
10.1038/s41416-022-01828-0
Authors: X. Luta, K. Diernberger, J. Bowden, J. Droney, P. Hall, J. Marti |
2022 |
Presence of Codes for Indication for Use in Clinical Practice Research Datalink Aurum: An Assessment of Benign Prostatic Hyperplasia Treatments
10.2147/clep.s360843
Authors: R. Persson, K. Hagberg, C. Vasilakis-Scaramozza, E. Yelland, T. Williams, P. Myles, S. Jick |
2022 |
A retrospective longitudinal cohort study of the clinical burden in myasthenia gravis
10.1186/s12883-022-02692-4
Authors: L. Harris, S. Graham, S. MacLachlan, A. Exuzides, S. Jacob |
2022 |
Background rates of five thrombosis with thrombocytopenia syndromes of special interest for COVID-19 vaccine safety surveillance: Incidence between 2017 and 2019 and patient profiles from 38.6 million people in six European countries
10.1002/pds.5419
Authors: E. Burn, X. Li, K. Kostka, H. Stewart, C. Reich, S. Seager, T. Duarte-Salles, S. Fernandez-Bertolin, M. Aragón, C. Reyes, E. Martinez-Hernandez, E. Marti, A. Delmestri, K. Verhamme, P. Rijnbeek, S. Horban, D. Morales, D. Prieto-Alhambra |
2022 |
Left-sided heart failure burden and mortality in idiopathic pulmonary fibrosis: a population-based study
10.1186/s12890-022-01973-5
Authors: A. Koteci, A. Morgan, L. Portas, H. Whittaker, C. Kallis, P. George, J. Quint |
2022 |
The impact of clinical risk conditions on influenza and pneumonia diagnoses in England: a nationally representative retrospective cohort study, 2010-2019
10.1017/s0950268822000838
Authors: D. Pokutnaya, M. Loiacono, H. Booth, R. Williams, C. Ma, J. Parker, H. Bricout, S. Farrow, J. Nealon |
2022 |
Clustering of physical health multimorbidity in people with severe mental illness: An accumulated prevalence analysis of United Kingdom primary care data
10.1371/journal.pmed.1003976
Authors: N. Launders, J. Hayes, G. Price, D. Osborn |
2022 |
Transparency of high-dimensional propensity score analyses: guidance for diagnostics and reporting
10.1002/pds.5412
Authors: J. Tazare, R. Wyss, J. Franklin, L. Smeeth, S. Evans, S. Wang, S. Schneeweiss, I. Douglas, J. Gagne, E. Williamson |
2022 |
First Maintenance Therapy for Chronic Obstructive Pulmonary Disease: Retrospective Analyses of US and UK Healthcare Databases
10.1007/s41030-021-00179-0
Authors: C. Bloom, J. Montonen, O. Jöns, E. Garry, S. Bhatt |
2022 |
Consultation rates in people with type 2 diabetes with and without vascular complications: a retrospective analysis of 141,328 adults in England
10.1186/s12933-021-01435-y
Authors: S. Abner, C. Gillies, S. Shabnam, F. Zaccardi, S. Seidu, M. Davies, T. Adeyemi, K. Khunti, D. Webb |
2022 |
Glucocorticoids and Risk of Venous Thromboembolism in Asthma Patients Aged 20-59 Years in the United Kingdom's CPRD 1995-2015
10.2147/clep.s341048
Authors: O. Ayodele, H. Cabral, D. McManus, S. Jick |
2022 |
β-Blockers and the Risk of Depression: A Matched Case-Control Study
10.1007/s40264-021-01140-5
Authors: D. Bornand, D. Reinau, S. Jick, C. Meier |
2022 |
Antipsychotic treatment patterns in Alzheimer's disease patients with agitation: a cohort study using the UK clinical practice research datalink
10.1080/03007995.2022.2029381
Authors: C. Tran, M. Bøg, S. Collings, M. Johnson, N. Qizilbash, S. Lind, R. Baker, K. Jørgensen |
2022 |
Estimation of recurrent atherosclerotic cardiovascular event risk in patients with established cardiovascular disease: the updated SMART2 algorithm
10.1093/eurheartj/ehac056
Authors: S. Hageman, A. McKay, P. Ueda, L. Gunn, T. Jernberg, E. Hagström, D. Bhatt, P. Steg, K. Läll, R. Mägi, Nordbø Gynnild, H. Ellekjær, I. Saltvedt, J. Tuñón, I. Mahíllo, Á Aceña, K. Kaminski, M. Chlabicz, E. Sawicka, T. Tillman, J. McEvoy, E. Di Angelantonio, I. Graham, D. De Bacquer, K. Ray, J. Dorresteijn, F. Visseren |
2022 |
Effectiveness of bisoprolol versus other β-blockers and other antihypertensive classes: a cohort study in the Clinical Practice Research Datalink
10.2217/cer-2021-0305
Authors: C. Foch, A. Allignol, T. Hohenberger, E. Boutmy, S. Schaefer, U. Hostalek |
2022 |
Blood eosinophils to guide inhaled maintenance therapy in a primary care COPD population
10.1183/23120541.00606-2021
Authors: H. Ashdown, M. Smith, E. McFadden, I. Pavord, C. Butler, M. Bafadhel |
2022 |
Glucagon-Like Peptide-1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: Multisite Population-Based Cohort Study
10.1093/aje/kwac021
Authors: R. Pradhan, E. Patorno, H. Tesfaye, S. Schneeweiss, H. Yin, J. Franklin, A. Pawar, C. Santella, O. H. Y. Yu, C. Renoux, L. Azoulay |
2022 |
Observational retrospective study calculating health service costs of patients receiving surgery for chronic rhinosinusitis in England, using linked patient-level primary and secondary care electronic data
10.1136/bmjopen-2021-055603
Authors: C. Clarke, E. Williamson, S. Denaxas, J. Carpenter, M. Thomas, H. Blackshaw, A. Schilder, C. Philpott, C. Hopkins, S. Morris |
2022 |
Long-Term patterns of cancer incidence among patients with and without type 2 diabetes in the United Kingdom
10.1016/j.diabres.2022.109229
Authors: R. Pradhan, O. Yu, R. Platt, L. Azoulay |
2022 |
The feasibility of pragmatic influenza vaccine randomized controlled real-world trials in Denmark and England
10.1038/s41541-022-00444-6
Authors: J. Nealon, D. Modin, R. Ghosh, D. Rudin, G. Gislason, H. Booth, J. Jensen, R. Williams, H. Shepherd, E. Yelland, H. Bricout, S. Chaves, T. Biering-Sørensen |
2022 |
Has the gout epidemic peaked in the UK? A nationwide cohort study using data from the Clinical Practice Research Datalink, from 1997 to across the COVID-19 pandemic in 2021
10.1136/annrheumdis-2021-221989
Authors: A. Abhishek, L. Tata, M. Mamas, A. Avery |
2022 |
Real-world weight change, adherence, and discontinuation among patients with type 2 diabetes initiating glucagon-like peptide-1 receptor agonists in the UK
10.1136/bmjdrc-2021-002517
Authors: T. Weiss, L. Yang, R. Carr, S. Pal, B. Sawhney, R. Boggs, S. Rajpathak, K. Iglay |
2022 |
Opioid use prior to total knee replacement: comparative analysis of trends in England and Sweden
10.1016/j.joca.2022.02.621
Authors: D. Yu, C. Hellberg, T. Appleyard, A. Dell'Isola, G. Thomas, A. Turkiewicz, M. Englund, G. Peat |
2022 |
The risk of all-cause and cause-specific mortality in people prescribed mirtazapine: an active comparator cohort study using electronic health records
10.1186/s12916-022-02247-x
Authors: R. Joseph, R. Jack, R. Morriss, R. Knaggs, D. Butler, C. Hollis, J. Hippisley-Cox, C. Coupland |
2022 |
Screening for type 2 diabetes after a diagnosis of gestational diabetes by ethnicity: A retrospective cohort study
10.1016/j.pcd.2022.03.008
Authors: E. Vounzoulaki, K. Khunti, J. Miksza, B. Tan, M. Davies, C. Gillies |
2022 |
Effectiveness and safety of apixaban vs. rivaroxaban in patients with atrial fibrillation and type 2 diabetes mellitus
10.1055/a-1798-2116
Authors: Roy Chowdhury, J. Michaud, O. H. Y. Yu, H. Yin, L. Azoulay, C. Renoux |
2022 |
UK poSt Arthroplasty Follow-up rEcommendations (UK SAFE): what does analysis of linked, routinely collected national data sets tell us about mid-late term revision risk after hip replacement? Retrospective cohort study
10.1136/bmjopen-2021-050877
Authors: L. Smith, C. Garriga, S. Kingsbury, R. Pinedo-Villanueva, A. Delmestri, N. Arden, M. Stone, P. Conaghan, A. Judge |
2022 |
Primary care and cancer: an analysis of the impact and inequalities of the COVID-19 pandemic on patient pathways
10.1136/bmjopen-2021-059374
Authors: T. Watt, R. Sullivan, A. Aggarwal |
2022 |
Reduction of Cardiovascular Disease and Mortality versus Risk of New Onset Diabetes with Statin Use in Patients with Rheumatoid Arthritis
10.1002/acr.24866
Authors: G. Ozen, S. Dell'Aniello, S. Pedro, K. Michaud, S. Suissa |
2022 |
Epidemiology of invasive meningococcal disease and sequelae in the United Kingdom during the period 2008 to 2017 - a secondary database analysis
10.1186/s12889-022-12933-3
Authors: S. Guedes, H. Bricout, E. Langevin, S. Tong, I. Bertrand-Gerentes |
2022 |
Serum potassium variability as a predictor of clinical outcomes in patients with cardiorenal disease or diabetes: a retrospective UK database study
10.1093/ckj/sfab225
Authors: G. James, J. Kim, C. Mellström, K. Ford, N. Jenkins, C. Tsang, M. Evans, P. McEwan |
2022 |
Intra-abdominal cancer risk with abdominal pain: a prospective cohort primary care study
10.3399/bjgp.2021.0552
Authors: S. Price, N. Gibson, W. Hamilton, A. King, E. Shephard |
2022 |
Effects of ACE inhibitors and angiotensin receptor blockers: protocol for a UK cohort study using routinely collected electronic health records with validation against the ONTARGET trial
10.1136/bmjopen-2021-051907
Authors: P. Baptiste, A. Wong, A. Schultze, M. Cunnington, J. Mann, C. Clase, C. Leyrat, L. Tomlinson, K. Wing |
2022 |
Angiotensin-converting enzyme inhibitors and angiotensin receptor blockers and risk of depression among older people with hypertension
10.1177/02698811221082470
Authors: T. van Sloten, P. Souverein, C. Stehouwer, J. Driessen |
2022 |
Association between covid-19 vaccination, SARS-CoV-2 infection, and risk of immune mediated neurological events: population based cohort and self-controlled case series analysis
10.1136/bmj-2021-068373
Authors: X. Li, B. Raventós, E. Roel, A. Pistillo, E. Martinez-Hernandez, A. Delmestri, C. Reyes, V. Strauss, D. Prieto-Alhambra, E. Burn, T. Duarte-Salles |
2022 |
Changes in heart failure management and long-term mortality over 10 years: observational study
10.1136/openhrt-2021-001888
Authors: A. Bottle, R. Newson, P. Faitna, B. Hayhoe, M. Cowie |
2022 |
Characteristics of New Users of Aclidinium Bromide, Aclidinium/Formoterol, and Other COPD Medications in the United Kingdom, Denmark, and Germany
10.1007/s40261-022-01120-2
Authors: E. Rivero-Ferrer, M. Olesen, E. Plana, J. Aguado, N. Saigi-Morgui, A. Rubino, S. Daoud, A. Lei, S. Perez-Gutthann, T. Schink, N. Kristiansen, J. Hallas, A. Pottegard, C. Rebordosa |
2022 |
Primary care clinical management following self-harm during the first wave of COVID-19 in the UK: population-based cohort study
10.1136/bmjopen-2021-052613
Authors: S. Steeg, M. Carr, L. Trefan, D. Ashcroft, N. Kapur, E. Nielsen, B. McMillan, R. Webb |
2022 |
Primary Prevention of Cardiovascular and Heart Failure Events With SGLT2 Inhibitors, GLP-1 Receptor Agonists, and Their Combination in Type 2 Diabetes
10.2337/dc21-1113
Authors: A. Wright, M. Carr, E. Kontopantelis, L. Leelarathna, H. Thabit, R. Emsley, I. Buchan, M. Mamas, T. van Staa, N. Sattar, D. Ashcroft, M. Rutter |
2022 |
Associations between multiple long-term conditions and mortality in diverse ethnic groups
10.1371/journal.pone.0266418
Authors: M. Stafford, H. Knight, J. Hughes, A. Alarilla, L. Mondor, Pefoyo Kone, W. Wodchis, S. Deeny |
2022 |
Impact of covid-19 on primary care contacts with children and young people aged 0-24 years in England; longitudinal trends study 2015-2020
10.3399/BJGP.2021.0643
Authors: K. Foley, E Maile, A. Bottle, F. Neale, R. Viner, S. Kenny, A. Majeed, D. Hargreaves, S. Saxena |
2022 |
Therapies for Long COVID in non-hospitalised individuals: from symptoms, patient-reported outcomes and immunology to targeted therapies (The TLC Study)
10.1136/bmjopen-2021-060413
Authors: S. Haroon, K. Nirantharakumar, S. Hughes, A. Subramanian, O. Aiyegbusi, E. Davies, P. Myles, T. Williams, G. Turner, J. Chandan, C. McMullan, J. Lord, D. Wraith, K. McGee, A. Denniston, T. Taverner, L. Jackson, E. Sapey, G. Gkoutos, K. Gokhale, E. Leggett, C. Iles, C. Frost, G. McNamara, A. Bamford, T. Marshall, D. Zemedikun, G. Price, S. Marwaha, N. Simms-Williams, K. Brown, A. Walker, K. Jones, K. Matthews, J. Camaradou, M. Saint-Cricq, S. Kumar, Y. Alder, D. Stanton, L. Agyen, M. Baber, H. Blaize, M. Calvert |
2022 |
Does Cardiovascular Mortality Overtake Cancer Mortality During Cancer Survivorship?: An English Retrospective Cohort Study
10.1016/j.jaccao.2022.01.102
Authors: H. Strongman, S. Gadd, A. Matthews, K. Mansfield, S. Stanway, A. Lyon, I. dos-Santos-Silva, L. Smeeth, K. Bhaskaran |
2022 |
Fluticasone-Based versus Budesonide-Based Triple Therapies in COPD: Real-World Comparative Effectiveness and Safety
10.1080/15412555.2022.2035705
Authors: S. Suissa, S. Dell'Aniello, P. Ernst |
2022 |
Discontinuation of Inhaled Corticosteroids from Triple Therapy in COPD: Effects on Major Outcomes in Real World Clinical Practice
10.1080/15412555.2022.2045265
Authors: S. Suissa, S. Dell'Aniello, P. Ernst |
2022 |
Associations of Cardiovascular and Non-Cardiovascular Comorbidities with Dementia Risk in Patients with Diabetes: Results from a Large UK Cohort Study
10.14283/jpad.2022.8
Authors: B. Zheng, B. Su, C. Udeh-Momoh, G. Price, I. Tzoulaki, E. Vamos, A. Majeed, E. Riboli, S. Ahmadi-Abhari, L. Middleton |